Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.Research Editor
jeffhans@uab.edu | (205) 209-2355Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.
Specific beats:
- Alabama Drug Discovery Alliance
- Biochemistry and Molecular Genetics
- Biomatrix Engineering and Regenerative Medicine
- Cell biology
- Center for Biophysical Sciences and Engineering
- CCTS
- Center for Metabolic Bone Disease
- Microbiology
- Neurobiology
- Comprehensive Neuroscience Center
- Pathology, research shared with MS2
- Pharmacology and Toxicology
- Physiology and Biophysics
- UAB Research Foundation/IIE
- Research Administration
The testing at UAB will investigate immune responses to the vaccine in mice — an important step before any Phase 1 human safety trial in patients later this year.
Francis Collins, M.D., Ph.D., visited UAB just as COVID-19 appeared near the NIH.
An immune reaction to COVID-19 infection called cytokine storm syndrome can be fatal to COVID-19 patients.
The tuberculosis bacteria induce increased hydrogen sulfide production by human macrophages, which increases pathogenesis.
Manipulating cellular metabolism may provide a promising therapeutic intervention in autoimmune diseases.
This suggests the possibility of cross-talk that heightens pathogenesis in Type 1 diabetes.
Chaplin has been chosen as a distinguished fellow by the American Association of Immunologists for his contributions to the field of immunology.
Influenza NS1 can bind with the cell’s RIG-I protein, blocking the innate immune response
Coronary microvascular dysfunction is a precursor to later heart disease, heart failure and possible death.
Unsuspected genetic variation among strains of mice can surreptitiously confound data results.